Daisuke Imanishi

718 total citations
38 papers, 431 citations indexed

About

Daisuke Imanishi is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Daisuke Imanishi has authored 38 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Hematology and 11 papers in Molecular Biology. Recurrent topics in Daisuke Imanishi's work include Acute Myeloid Leukemia Research (11 papers), T-cell and Retrovirus Studies (9 papers) and Vector-Borne Animal Diseases (6 papers). Daisuke Imanishi is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), T-cell and Retrovirus Studies (9 papers) and Vector-Borne Animal Diseases (6 papers). Daisuke Imanishi collaborates with scholars based in Japan, United Kingdom and United States. Daisuke Imanishi's co-authors include Yoshitaka Imaizumi, Yasushi Miyazaki, Masao Tomonaga, Hideki Tsushima, Tomoko Hata, Jun Taguchi, Yasushi Sawayama, Shinichiro Yoshida, Kazuo Yamamoto and Hidehiro Itonaga and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Daisuke Imanishi

37 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daisuke Imanishi Japan	14	195	129	108	86	77	38	431
Kana Washio Japan	9	179 0.9×	81 0.6×	182 1.7×	113 1.3×	162 2.1×	44	555
Yoko Kubuki Japan	12	213 1.1×	210 1.6×	260 2.4×	112 1.3×	86 1.1×	34	628
Naruhiko Takasawa Japan	12	196 1.0×	53 0.4×	127 1.2×	30 0.3×	146 1.9×	21	484
C Mikuni Japan	12	154 0.8×	159 1.2×	96 0.9×	86 1.0×	159 2.1×	36	513
M Maruyama Japan	5	177 0.9×	254 2.0×	62 0.6×	49 0.6×	147 1.9×	7	411
Hideo Ohtsubo Japan	13	320 1.6×	49 0.4×	71 0.7×	151 1.8×	59 0.8×	35	451
S Konda Japan	8	275 1.4×	85 0.7×	81 0.8×	139 1.6×	123 1.6×	24	450
Masaharu Nohgawa Japan	10	176 0.9×	73 0.6×	74 0.7×	19 0.2×	115 1.5×	45	380
Kohsuke Yanagisawa Japan	14	166 0.9×	198 1.5×	140 1.3×	20 0.2×	129 1.7×	29	520
Yuya Sasaki Japan	12	156 0.8×	43 0.3×	37 0.3×	50 0.6×	185 2.4×	26	403

Countries citing papers authored by Daisuke Imanishi

Since Specialization

Citations

This map shows the geographic impact of Daisuke Imanishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Imanishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Imanishi more than expected).

Fields of papers citing papers by Daisuke Imanishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Imanishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Imanishi. The network helps show where Daisuke Imanishi may publish in the future.

Co-authorship network of co-authors of Daisuke Imanishi

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Imanishi. A scholar is included among the top collaborators of Daisuke Imanishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Imanishi. Daisuke Imanishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Itonaga, Hidehiro, Daisuke Niino, Hiroaki Miyoshi, et al.. (2020). Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group. International Journal of Hematology. 112(4). 524–534. 1 indexed citations

Imanishi, Daisuke, et al.. (2019). [Enteropathy-associated T-cell lymphoma coexisting with composite lymphoma composed of DLBCL and PTCL].. PubMed. 60(3). 197–202. 1 indexed citations

Sato, Shinya, Hidehiro Itonaga, Yasushi Sawayama, et al.. (2018). Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm. International Journal of Hematology. 108(2). 213–217. 2 indexed citations

Mishima, Hiroyuki, Akira Kinoshita, Yoshibumi Nakane, et al.. (2017). Detection of de novo single nucleotide variants in offspring of atomic-bomb survivors close to the hypocenter by whole-genome sequencing. Journal of Human Genetics. 63(3). 357–363. 19 indexed citations

Mori, Sayaka, Hiroo Hasegawa, Daisuke Sasaki, et al.. (2016). Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting. Clinica Chimica Acta. 462. 166–173. 6 indexed citations

Hata, Tomoko, Daisuke Imanishi, & Yasushi Miyazaki. (2014). Lessons from the Atomic Bomb About Secondary MDS. Current Hematologic Malignancy Reports. 9(4). 407–411. 1 indexed citations

Makiyama, Junya, Yoshitaka Imaizumi, Hideki Tsushima, et al.. (2014). Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience. International Journal of Hematology. 100(5). 464–472. 8 indexed citations

Akazawa, Yuko, Fuminao Takeshima, Hiroyuki Yajima, et al.. (2014). Infliximab therapy for Crohn’s-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report. BMC Research Notes. 7(1). 382–382. 11 indexed citations

Itonaga, Hidehiro, Jun Taguchi, Takuya Fukushima, et al.. (2013). Distinct Clinical Features of Infectious Complications in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis in the Nagasaki Transplant Group. Biology of Blood and Marrow Transplantation. 19(4). 607–615. 18 indexed citations

10.

Hata, Tomoko, Hideki Tsushima, Yoshitaka Imaizumi, et al.. (2013). Long-term outcome of immunosuppressive therapy for Japanese patients with lower-risk myelodysplastic syndromes. International Journal of Hematology. 98(6). 687–693. 5 indexed citations

11.

Fukushima, Takuya, Hidehiro Itonaga, Yukiyoshi Moriuchi, et al.. (2013). Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network. International Journal of Hematology. 97(4). 485–490. 18 indexed citations

12.

Ando, Koji, Hideki Tsushima, Daisuke Imanishi, et al.. (2013). Mutations in the Nucleolar Phosphoprotein, Nucleophosmin, Promote the Expression of the Oncogenic Transcription Factor MEF/ELF4 in Leukemia Cells and Potentiates Transformation. Journal of Biological Chemistry. 288(13). 9457–9467. 13 indexed citations

13.

Itonaga, Hidehiro, Hideki Tsushima, Tomoko Hata, et al.. (2012). Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa. International Journal of Hematology. 95(2). 209–213. 16 indexed citations

14.

Fukushima, Takuya, Jun Taguchi, Yukiyoshi Moriuchi, et al.. (2011). Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: The Nagasaki Transplant Group experience. International Journal of Hematology. 94(4). 390–394. 7 indexed citations

15.

Tsushima, Hideki, Koji Ando, Hidehiro Itonaga, et al.. (2011). Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts. International Journal of Hematology. 94(1). 81–89. 9 indexed citations

16.

Ando, Koji, Yasushi Miyazaki, Yasushi Sawayama, et al.. (2010). High expression of 67-kDa laminin receptor relates to the proliferation of leukemia cells and increases expression of GM-CSF receptor. Experimental Hematology. 39(2). 179–186.e4. 6 indexed citations

17.

Morita, Yasuyoshi, Akihisa Kanamaru, Yasushi Miyazaki, et al.. (2010). Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group. International Journal of Hematology. 91(1). 97–103. 13 indexed citations

18.

Tsushima, Hideki, Koji Ando, Yasushi Sawayama, et al.. (2006). Chemokine expression in human erythroid leukemia cell line AS-E2: Macrophage inflammatory protein-3α/CCL20 is induced by inflammatory cytokines. Experimental Hematology. 34(1). 19–26. 12 indexed citations

19.

Imaizumi, Yoshitaka, Kazuo Yamamoto, Daisuke Imanishi, et al.. (2002). Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-κB pathway. International Immunology. 14(2). 147–155. 38 indexed citations

20.

Tsushima, Hideki, et al.. (1999). Fas Antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-γ and tumor necrosis factor-α and potentiates apoptotic death. Experimental Hematology. 27(3). 433–440. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact